-
2
-
-
0024299370
-
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
-
Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
-
(1988)
Science
, vol.240
, pp. 622-630
-
-
Mahley, R.W.1
-
3
-
-
0023860891
-
Apolipoprotein E polymorphism and atherosclerosis
-
Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8 (1988) 1-21
-
(1988)
Arteriosclerosis
, vol.8
, pp. 1-21
-
-
Davignon, J.1
Gregg, R.E.2
Sing, C.F.3
-
4
-
-
0037318641
-
The molecular genetics of cardiovascular disease: clinical implications
-
Stephens J.W., and Humphries S.E. The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 253 (2003) 120-127
-
(2003)
J Intern Med
, vol.253
, pp. 120-127
-
-
Stephens, J.W.1
Humphries, S.E.2
-
5
-
-
0027194791
-
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
-
Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Strittmatter, W.J.3
-
6
-
-
0032587143
-
Competition of Ab amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
-
Winkler K., Scharnagl H., Tisljar U., et al. Competition of Ab amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J Lipid Res 40 (1999) 447-455
-
(1999)
J Lipid Res
, vol.40
, pp. 447-455
-
-
Winkler, K.1
Scharnagl, H.2
Tisljar, U.3
-
7
-
-
3142706539
-
Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease
-
Song Y., Stampfer M.J., and Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141 (2004) 137-147
-
(2004)
Ann Intern Med
, vol.141
, pp. 137-147
-
-
Song, Y.1
Stampfer, M.J.2
Liu, S.3
-
8
-
-
0023393613
-
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype
-
Kesaniemi Y.A., Ehnholm C., and Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80 (1987) 578-581
-
(1987)
J Clin Invest
, vol.80
, pp. 578-581
-
-
Kesaniemi, Y.A.1
Ehnholm, C.2
Miettinen, T.A.3
-
9
-
-
0032948510
-
Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
-
Mamotte C.D., Sturm M., Foo J.I., van Bockxmeer F.M., and Taylor R.R. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol 276 (1999) E553-E557
-
(1999)
Am J Physiol
, vol.276
-
-
Mamotte, C.D.1
Sturm, M.2
Foo, J.I.3
van Bockxmeer, F.M.4
Taylor, R.R.5
-
10
-
-
34548736492
-
Association of apolipoprotein E genotypes with lipid levels and coronary risk
-
Bennet A.M., Di Angelantonio E., Ye Z., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298 (2007) 1300-1311
-
(2007)
JAMA
, vol.298
, pp. 1300-1311
-
-
Bennet, A.M.1
Di Angelantonio, E.2
Ye, Z.3
-
11
-
-
0042821576
-
Impact of dyslipidemia in end-stage renal disease
-
Prichard S.S. Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14 (2003) S315-S320
-
(2003)
J Am Soc Nephrol
, vol.14
-
-
Prichard, S.S.1
-
12
-
-
0032973549
-
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators
-
Wanner C., Krane V., Ruf G., Marz W., and Ritz E. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators. Kidney Int Suppl 71 (1999) S222-S226
-
(1999)
Kidney Int Suppl
, vol.71
-
-
Wanner, C.1
Krane, V.2
Ruf, G.3
Marz, W.4
Ritz, E.5
-
13
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
-
(2005)
N Engl J Med
, vol.353
, pp. 238-248
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
-
14
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 (2009) 1395-1407
-
(2009)
N Engl J Med
, vol.360
, pp. 1395-1407
-
-
Fellstrom, B.C.1
Jardine, A.G.2
Schmieder, R.E.3
-
15
-
-
4644272251
-
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics
-
Wanner C., Krane V., and Marz W. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 27 (2004) 259-266
-
(2004)
Kidney Blood Press Res
, vol.27
, pp. 259-266
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
-
16
-
-
0024284028
-
A simple salting out procedure for extracting DNA from human nucleated cells
-
Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
-
(1988)
Nucleic Acids Res
, vol.16
, pp. 1215
-
-
Miller, S.A.1
Dykes, D.D.2
Polesky, H.F.3
-
17
-
-
0030870822
-
Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes
-
Zivelin A., Rosenberg N., Peretz H., et al. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43 (1997) 1657-1659
-
(1997)
Clin Chem
, vol.43
, pp. 1657-1659
-
-
Zivelin, A.1
Rosenberg, N.2
Peretz, H.3
-
18
-
-
0034805702
-
Atherogenic lipoproteins in end-stage renal disease
-
Shoji T., Ishimura E., Inaba M., Tabata T., and Nishizawa Y. Atherogenic lipoproteins in end-stage renal disease. Am J Kidney Dis 38 (2001) S30-S33
-
(2001)
Am J Kidney Dis
, vol.38
-
-
Shoji, T.1
Ishimura, E.2
Inaba, M.3
Tabata, T.4
Nishizawa, Y.5
-
19
-
-
30744476783
-
Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis
-
Ikewaki K., Schaefer J.R., Frischmann M.E., et al. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 2615-2622
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2615-2622
-
-
Ikewaki, K.1
Schaefer, J.R.2
Frischmann, M.E.3
-
20
-
-
50849099502
-
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
-
Winkler K., Wanner C., Drechsler C., et al. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients. Eur Heart J (2008)
-
(2008)
Eur Heart J
-
-
Winkler, K.1
Wanner, C.2
Drechsler, C.3
-
21
-
-
56549092147
-
Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis
-
Krane V., Winkler K., Drechsler C., et al. Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney Int (2008)
-
(2008)
Kidney Int
-
-
Krane, V.1
Winkler, K.2
Drechsler, C.3
-
22
-
-
9644267020
-
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)
-
Marz W., Scharnagl H., Hoffmann M.M., Boehm B.O., and Winkelmann B.R. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 25 (2004) 2109-2119
-
(2004)
Eur Heart J
, vol.25
, pp. 2109-2119
-
-
Marz, W.1
Scharnagl, H.2
Hoffmann, M.M.3
Boehm, B.O.4
Winkelmann, B.R.5
|